Old Web
English
Sign In
Acemap
>
Paper
>
MBRS-58. VISMODEGIB NANOPARTICLE ENHANCES TUMOR TARGETING IN AN IN VIVO MEDULLOBLASTOMA MODEL
MBRS-58. VISMODEGIB NANOPARTICLE ENHANCES TUMOR TARGETING IN AN IN VIVO MEDULLOBLASTOMA MODEL
2018
Hiroto Kiguchi
Yosef Shamay
Janki Shah
Jake Vaynshteyn
Daniel A. Heller
Praveen Raju
Keywords:
Quantitative Real-Time Polymerase Chain Reaction
Pathology
Vismodegib
In vivo
Zinc Finger Protein GLI1
P-selectin
Erinaceidae
Medulloblastoma
Brain tumor childhood
Medicine
tumor targeting
Nanoparticle
bone development
Cancer research
single dose regimen
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]